04:30:26 EDT Sun 06 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Verses AI Inc (2)
Symbol VERS
Shares Issued 26,239,469
Close 2025-06-04 C$ 5.12
Market Cap C$ 134,346,081
Recent Sedar Documents

Verses AI converts Genius beta user into first contract

2025-06-05 10:03 ET - News Release

Mr. Michael Wadden reports

VERSES ANNOUNCES MAJOR GLOBAL INVESTMENT FIRM UPGRADES TO GENIUS ENTERPRISE BASED ON EARLY PROJECT SUCCESS

A major global investment firm has converted to an enterprise contract with Verses AI Inc. on the basis of the results achieved during its participation in the company's Genius beta program.

This firm validated Genius beta in early 2025, and based on the initial results, it has signed up for a renewable enterprise licence, which provides it with access to unlimited inferences. The contract contains provisions for outcome-based pricing in the future, after an initial period of fixed payments.

Genius, which uses active inference models and techniques that are particularly well suited to handling complex, layered reasoning, is being explored to be used as an alternative to current artificial intelligence.

"We are thrilled at the early results of Genius and believe that the migration from the Genius beta program to the Genius commercial enterprise version is a strong vote of confidence in Genius's potential," said Michael Wadden, Verses's chief commercial officer. "We are excited by the opportunity to unlock significant business value with one of the largest global financial institutions as we begin to scale Genius into the market."

About Verses AI Inc.

Verses is a cognitive computing company focused on building next-generation intelligent software systems modelled after the wisdom and genius of nature. Designed around first principles found in science, physics and biology, the company's flagship product, Genius, is an agentic enterprise intelligence platform designed to generate reliable, domain-specific predictions and decisions under uncertainty.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.